Topic
-
Interpretation of new healthcare regulations in China, Singapore, Japan, Korea, ASEAN, and Australia
-
Analysis of the registration process and market access strategies for healthcare products
-
Assessment of quality assurance and state of compliance for medical devices and pharmaceuticals
-
Information and future trends for innovation in drugs and medical devices
-
Thorough explanation of IVD and diagnostics product development in the APAC region
-
Latest updates regarding clinical trials and regulation for healthcare products in the Asia Pacific region
-
Exchanges between representatives of companies and government regulators, in the interest of developing the industry
First day
feature presentations from officials in regulatory agencies across the region, including Singapore, South Korea, Japan, Australia, India, and the ASEAN trading bloc, providing official interpretations for newly promulgated policies that effect the healthcare industry.
Important issues include regulations relating to medical device approval and registration, pharmaceutical product registration, and the global “harmonization” of regulations across jurisdictions.
Final day
shift its emphasis to topics in the private sector, relating to optimal operational practices for healthcare companies.
Representatives from leading companies in the field will detail their experiences in obtaining market access for products, achieving quality assurance, and managing successful clinical trials.
Click here to register and for more details.
Singapore | April 27-28, 2017